Lilac Agriculture has raised $2.3 million to enhance rhizobial inoculants, aiming for better nitrogen fixation and yield transparency for farmers.
Lilac Agriculture has successfully completed an oversubscribed seed funding round, raising $2.3 million to confront the challenges surrounding rhizobial inoculants, commonly used for enhancing crop nitrogen efficiency. This funding will allow the company to focus on developing next-generation inoculants that improve yields in diverse soil conditions for pulse crop growers.
The financing round was spearheaded by Innova, alongside support from other notable investors including 701 Fund, Ag Ventures Alliance, and Evergreen Climate Innovations. This injection of capital will propel Lilac's dual-focused platform, which seeks to enhance the performance of nitrogen-fixing bacteria while ensuring successful competition against native soil bacteria.
The Role of Inoculants in Agriculture
In the agricultural landscape, particularly among pulse crops, inoculation with rhizobia—a type of beneficial bacteria—is a routine practice. These bacteria colonize the roots of plants and create nodules that convert atmospheric nitrogen into a usable form for the plant. However, Lilac CEO Natalie DiNicola points out a significant concern: native soil bacteria often outcompete these commercial inoculants, leading to a situation where farmers may be investing in products that do not deliver clear benefits.
“It’s not sufficient to have effective inoculants if they can't establish themselves in the root system,” DiNicola explains. “We've seen instances where the bacteria present in nodules are not representative of the purchased products.” This lack of transparency has been likened to a “black box” affecting farmer confidence in inoculant efficacy.
Innovative Approach to Inoculant Development
Founded in 2024 by a team including North Dakota State University assistant professor Dr. Barney Geddes and agtech veterans Matt Crisp and Tom Snipes, Lilac Agriculture aims to demystify the inoculant process. The company is leveraging a rigorous screening process using NDSU's extensive microbial collection to identify strains with optimal nitrogen-fixing capabilities and competitiveness.
Initial assessments of nitrogen fixation occur under nitrogen-limiting conditions, while molecular markers allow the team to trace which strains effectively colonize roots and nodules. "The idea is to trust but verify; we’re checking if our product is actually present in the nodules," notes DiNicola.
Through this assessment, Lilac developed its first commercial strain, PL11, representing a naturally selected INOCULANT. The company is exploring a "guided evolution" phase wherein selection pressures are applied in laboratory settings to further refine these microbial strains.
Promising Early Results
Early field trials involving PL11 have indicated promising results, with the product demonstrating an aggregate yield increase of 11% compared to untreated crops, and a 6% increase against conventional inoculants. These outcomes underscore the potential for improved nodule occupancy to correlate with enhanced yield, although DiNicola acknowledges the complexity in attributing yield gains to singular interventions due to various influencing factors.
“We’re passionate about providing the transparency farmers deserve,” DiNicola adds, emphasizing that their approach aims to reveal the true impact of inoculants, which is often obscured in traditional practices.
Market Strategy and Future Prospects
Lilac Agriculture is focused initially on pulse crop producers in the Northern Plains, where an estimated 90% of growers utilize inoculants. DiNicola observes that many farmers view inoculation as a necessary yet opaque expense akin to “insurance.” By offering PL11 as a competitively priced, shelf-stable powder, the company seeks to enhance value without requiring growers to face higher risks.
After a soft launch, during which they placed PL11 on a limited acreage of peas and lentils, Lilac anticipates expanding its market reach next season and plans to introduce products designed for dry beans. Additionally, the company is gearing up for registration in Canada, recognizing its potential as a significant market for peas and lentils.
Expanding the Product Range
Looking ahead, Lilac aims to broaden its product lineup beyond pulse crops. Soybeans, which also rely on nitrogen-fixing symbiosis with rhizobia, are viewed as a logical next step. DiNicola does note, however, that transitioning to mainstream cereals like corn presents challenges due to the absence of effective nodulation. Nonetheless, she reassures that the foundational concepts and methodologies established through their platform can ultimately be adapted for these crops, emphasizing their long-term vision.
Funding and Future Development
This latest funding comes during a challenging period for agrifood tech startups, but Lilac’s operational model attracted investor interest. The company’s goal is to achieve profitability with around $5 million in total capital, which the new funding round will help support. DiNicola, who brings extensive experience from organizations like Monsanto, underlines the importance of quickly delivering practical solutions that integrate advanced technological insights into existing agricultural practices.
As Lilac Agriculture moves forward with expanded field trials, further research and development efforts, and the commercialization of PL11, the company is positioning itself to respond effectively to modern agricultural needs, transforming how farmers view and utilize inoculants.
Further reading:
Can microbes supply half a crop’s nitrogen? Pivot Bio thinks so
Switch Bioworks tests ‘switchable’ nitrogen-fixing microbes in corn for fertilizer
Mafix raises $5.4m to activate silicate rock into climate-smart fertilizer
Stenon bags $20.5m to combat fertilizer price hikes with better nitrogen management
The post Exclusive: Lilac Agriculture raises $2.3m to tackle inoculants’ ‘black box’ problem appeared first on AgFunderNews.
